Table 3 mRNA expression of SELENBP1 versus clinicopathologic parameters in RCC

Pathologic T-stage (Low versus High stage)

0.034

pT1–2 (114)

0.64 (0.51–0.81)

pT3–4 (25)

0.36 (0.22–0.57)

T stage (individual stage)

0.030

pT1 (93)

0.64 (0.50–0.82)

pT2 (21)

0.55 (0.35–0.70)

pT3 (20)

0.40 (0.23–0.61)

pT4 (5)

0.23 (0.10–0.41)

N stage

0.267

N0 or Nx (129)

0.60 (0.48–0.74)

N⁺ (10)

0.38 (0.16–0.86)

M stage

0.855

M0 or Mx

0.58 (0.47–0.72)

M1

0.54 (0.24–1.21)

Nuclear grade

1 (25)

0.63 (0.43–0.94)

0.042

2 (58)

0.59 (0.42–0.83)

3 (43)

0.70 (0.48–1.03)

4 (13)

0.23 (0.11–0.49)

Progression

0.009

No (115)

0.65 (0.52–0.82)

Yes (24)

0.31 (0.19–0.52)

Cancer-specific death

0.002

No (122)

0.65 (0.52–0.81)

Yes (17)

0.24 (0.13–0.421)